{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-049570","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2024-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.988137+00:00","generated_at":"2026-05-29T11:46:40.488394+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Context Therapeutics enters $75M at-the-market equity offering with Leerink Partners","bullets":["ATM facility allows sale of up to $75M of common stock from time to time.","Leerink Partners receives 3.0% commission on gross proceeds; company reimburses certain expenses.","Net proceeds to fund R&D of product candidates and working capital / general corporate purposes.","Shares offered under effective S-3 filed Nov 2022; prospectus supplement dated Dec 2, 2024.","Company not obligated to sell any shares; agreement terminates upon full sale or earlier termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-049570","json":"https://secwatch.observer/filing/0001628280-24-049570.json","markdown":"https://secwatch.observer/filing/0001628280-24-049570.md","text":"https://secwatch.observer/filing/0001628280-24-049570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000162828024049570/0001628280-24-049570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000162828024049570/cntx-20241202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T11:46:40.488394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}